Biogen Inc.

NASDAQ Global Select
Bullish +75

Stocks making the biggest moves premarket: Versant, Biogen, Bullish, Cisco and more

🧬 Biogen shares advanced 4% after announcing its experimental Alzheimer's drug will proceed to a phase 3 trial despite failing the primary goal in phase 2.

🧠 The biopharmaceutical company stated that the drug still demonstrated cognitive benefits for patients.

πŸ“ˆ Versant Media Group shares jumped 14.5% following reported revenue growth in content licensing and digital platforms during the first quarter.

πŸ“‰ Overall revenue slipped for Versant due to continued declines in linear distribution for its pay TV networks and advertising businesses.

πŸ’° Adjusted EBITDA came in at $704 million, significantly above the $608 million estimated by analysts polled by FactSet.

🧊 Yeti Holdings shares rose 10% after beating top and bottom line estimates for the first quarter.

πŸ’΅ Yeti reported adjusted earnings of 26 cents per share versus an expected 18 cents from analysts.

πŸ“¦ Revenue of $380.4 million also topped the consensus estimate of $374.7 million.

πŸ“‰ Bullish shares tumbled 9% after reporting disappointing first-quarter results that missed analyst expectations.

πŸ’Έ Adjusted net income was $20.3 million, short of the $23.9 million expected by analysts polled by FactSet.

πŸ“‰ Adjusted revenue of $92.8 million also came in below the $94.9 million consensus estimate.

πŸš€ Cisco Systems shares surged 15% after issuing third-quarter results and guidance that beat Wall Street expectations.

πŸ’° For the current quarter, Cisco expects adjusted earnings between $1.16 and $1.18 per share on revenue of $16.7 billion to $16.9 billion.

πŸ“‰ Analysts were looking for adjusted earnings of $1.07 per share and revenue of $15.82 billion, according to LSEG data.

βœ‚οΈ Cisco also beat projections for its last quarter and announced plans to cut almost 4,000 jobs.

🎟️ StubHub shares popped 14% after posting first-quarter revenue of $446 million and adjusted EBITDA of $72.1 million.

πŸ’° Analysts polled by LSEG had expected $432 million in revenue and $65.1 million in EBITDA.

πŸ“‰ Doximity shares stumbled 23% after sharing current-quarter and full-year revenue guidance that fell short of analysts' expectations.

πŸ’Έ Fourth-quarter adjusted earnings of 26 cents per share also came below the 28 cents analysts were looking for.

πŸ” Jack in the Box stock added 4% after posting second-quarter adjusted EBITDA of $51.3 million, exceeding the $50.3 million analysts expected.

πŸ“‰ However, the company's adjusted earnings and revenue missed consensus estimates.

πŸ’» Nvidia shares added 2% after the U.S. cleared the sale of its H200 AI-chip to about 10 Chinese firms.

🚫 No delivery has been made so far, according to Reuters reporting citing sources.

🏎️ Honda Motor shares rose 3% despite posting its first annual loss in nearly 70 years due to $9 billion in restructuring costs for its EV business.

πŸ“ˆ Full-year guidance for 2027 came in above expectations and the company maintained its dividend.

β›΅ Viking Holdings climbed 3.4% after posting first-quarter revenue of $1.05 billion, above the $1.01 billion expected from analysts.

πŸ’Έ The cruise operator reported an 11 cents loss per share, which was in line with expectations.

πŸ’³ Klarna shares rallied 16% after reporting $1 billion in revenue for its first quarter, topping the $944.1 million expected by analysts.

πŸ“ˆ Klarna posted $17 million in operating income, though it is unclear if that is comparable to the consensus estimate of $15.6 million.

Bullish Signals
  • Biogen shares advanced 4% after announcing its experimental Alzheimer's drug will advance into a phase 3 trial, demonstrating continued progress despite missing the main goal in phase 2.
  • The Biogen drug showed cognitive benefits, providing a positive signal for future development potential.
  • Versant Media Group reported revenue growth across its content licensing and digital platforms in the first quarter, highlighting strength in key segments.
  • Versant's adjusted EBITDA came in at $704 million, significantly above the $608 million analyst estimates.
  • Yeti Holdings jumped 10% after beating top and bottom line expectations with adjusted earnings of 26 cents per share versus 18 cents expected.
  • Yeti reported revenue of $380.4 million, topping the $374.7 million consensus estimate.
  • Cisco Systems shares surged 15% after issuing third-quarter results and guidance that beat Wall Street's expectations on both earnings and revenue.
  • Cisco sees current quarter adjusted earnings between $1.16 to $1.18 per share, exceeding the $1.07 per share analyst forecast.
  • Cisco also beat projections for its last quarter, demonstrating consistent strong performance across multiple periods.
  • StubHub popped 14% after posting first-quarter revenue of $446 million and adjusted EBITDA of $72.1 million, both above consensus estimates.
  • Jack in the Box added 4% after posting second-quarter adjusted EBITDA of $51.3 million, exceeding the $50.3 million analysts were looking for.
  • Nvidia shares added 2% following news that the U.S. cleared the sale of its AI-chip, H200, to about 10 Chinese firms.
  • Honda Motor maintained its dividend and posted full-year guidance for 2027 above expectations, offsetting recent restructuring costs.
  • Viking Holdings climbed 3.4% after posting first-quarter revenue of $1.05 billion, above the $1.01 billion expected from analysts.
  • Klarna shares rallied 16% after reporting $1 billion in revenue for its first quarter, topping the $944.1 million expected from analysts.
  • Klarna posted $17 million in operating income, which appears to exceed the consensus estimate of $15.6 million.
Risk Factors
  • Biogen's experimental Alzheimer's drug failed to meet the main goal of its phase 2 trial despite advancing to a phase 3 trial.
  • Bullish cryptocurrency exchange saw adjusted net income of $20.3 million, which fell short of the $23.9 million expected by analysts.
  • Bullish's adjusted revenue of $92.8 million missed the $94.9 million consensus estimate.
  • Doximity shares stumbled 23% after current-quarter and full-year revenue guidance fell short of analysts' expectations.
  • Doximity's fourth-quarter adjusted earnings of 26 cents per share came below the 28 cents analysts were looking for.
  • Jack in the Box missed consensus estimates on both adjusted earnings and revenue despite beating EBITDA targets.
  • Honda Motor posted its first annual loss in nearly 70 years due to $9 billion in costs to restructure its electric-vehicle business.
Full Analysis
Biogen shares advanced 4% in premarket trading after the company announced that its experimental Alzheimer's drug will proceed into a phase 3 trial. This decision comes despite the drug failing to meet its primary endpoint in the preceding phase 2 trial. The company stated that the drug still demonstrated cognitive benefits, which appears to have driven investor optimism regarding its potential future development path.